Upgrade to SI Premium - Free Trial

60 Degrees (SXTP)

0.89 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

60 Degrees Pharmaceuticals to report babesiosis trial data in January 2027 October 6, 2026 8:10 AM - StreetInsider 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA October 6, 2026 8:10 AM - Globe NewsWire Form 8-K 60 DEGREES PHARMACEUTICA For: Oct 06 October 6, 2026 7:46 AM - SEC Filing 60 Degrees Pharmaceuticals and Exyn Technologies Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV October 2, 2026 9:01 AM - StreetInsider 60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar October 1, 2026 8:03 AM - Globe NewsWire Form 8-K 60 DEGREES PHARMACEUTICA For: Sep 12 September 22, 2026 5:10 PM - SEC Filing Form 8-K 60 DEGREES PHARMACEUTICA For: Sep 12 September 14, 2026 4:06 PM - SEC Filing Form EFFECT 60 DEGREES PHARMACEUTICA August 26, 2026 6:05 AM - SEC Filing Form DEL AM 60 DEGREES PHARMACEUTICA August 17, 2026 11:32 AM - SEC Filing Form S-3 60 DEGREES PHARMACEUTICA August 14, 2026 4:31 PM - SEC Filing 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results August 14, 2026 3:47 PM - Globe NewsWire Form 10-Q 60 DEGREES PHARMACEUTICA For: Jun 30 August 14, 2026 3:35 PM - SEC Filing Form 8-K 60 DEGREES PHARMACEUTICA For: Aug 05 August 6, 2026 4:10 PM - SEC Filing Form SCHEDULE 13G 60 DEGREES PHARMACEUTICA Filed by: Lind Global Fund III LP August 5, 2026 5:12 PM - SEC Filing Form 8-K 60 DEGREES PHARMACEUTICA For: Jul 30 August 4, 2026 4:45 PM - SEC Filing 60 Degrees Pharmaceuticals raises $1M in private placement July 30, 2026 2:23 PM - StreetInsider 60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules July 30, 2026 2:23 PM - Globe NewsWire Form 3 60 DEGREES PHARMACEUTICA For: Jul 22 Filed by: Knight Therapeutics Inc. July 29, 2026 4:07 PM - SEC Filing Form SCHEDULE 13G 60 DEGREES PHARMACEUTICA Filed by: Knight Therapeutics Inc. July 29, 2026 4:06 PM - SEC Filing 60 Degrees Pharmaceuticals Announces Minimum Enrollment Achieved in Hospitalized Babesiosis Study; Interim Data Readout Planned by October 6, 2026 July 29, 2026 4:03 PM - Globe NewsWire Full Article List